{"id":49124,"date":"2023-07-25T14:11:48","date_gmt":"2023-07-25T12:11:48","guid":{"rendered":"https:\/\/newserver.fyb.de\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/"},"modified":"2023-07-25T14:11:48","modified_gmt":"2023-07-25T12:11:48","slug":"cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/","title":{"rendered":"Cancer Treatment: Series\u2011A for NVision Imaging Technologies for USD 30 million."},"content":{"rendered":"<p>Ulm, Germany \u2014 NVision Imaging Tech\u00adno\u00adlo\u00adgies GmbH has successfully closed a Series A finan\u00adcing round with a volume of more than USD 30 million. Both exis\u00adting and new inves\u00adtors, inclu\u00adding promi\u00adnent venture capi\u00adtal inves\u00adtors from the U.S., Israel, Luxem\u00adbourg, Portu\u00adgal and invest\u00adment compa\u00adnies from German Landes\u00adban\u00adken, parti\u00adci\u00adpa\u00adted in the finan\u00adcing round to support NVision Imaging Tech\u00adno\u00adlo\u00adgies in the deve\u00adlo\u00adp\u00adment of meta\u00adbo\u00adlic imaging systems for adap\u00adtive cancer treatment.<\/p>\n<p>NVision Imaging Tech\u00adno\u00adlo\u00adgies GmbH is an award-winning deep-tech startup based in Ulm, Germany, with more than 50 employees from more than 10 count\u00adries. Foun\u00added in 2015, the company lever\u00ada\u00adges advan\u00adces in quan\u00adtum physics to enable the first routine, conve\u00adni\u00adent, and afforda\u00adble use of magne\u00adtic reso\u00adnance imaging (MRI) to assess pati\u00adents\u2019 early response to cancer therapy at the meta\u00adbo\u00adlic level. NVision plans to deploy its pola\u00adri\u00adzer systems in more than 50 cancer centers world\u00adwide by&nbsp;2025.<\/p>\n<p>POELLATH has been NVisi\u00adon\u2019s perma\u00adnent legal advi\u00adsor since the begin\u00adning. In this Series A finan\u00adcing round, POELLATH advi\u00adsed NVision with the follo\u00adwing Munich team:<\/p>\n<p>Dr. Michael Inhes\u00adter (Part\u00adner, Lead Part\u00adner, M&amp;A\/ Venture Capital)<br>\nAndreas K\u00fchnert, LL.M. (Coun\u00adsel, Co-Lead, M&amp;A\/ Venture Capital)<br>\nDr. Nico Fischer (Part\u00adner,&nbsp;Taxes)<br>\nAndreas Gesell (Asso\u00adciate, Tax)<br>\nLeonid Guggen\u00adber\u00adger (Asso\u00adciate, M&amp;A\/ Venture Capital)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ulm, Germany \u2014 NVision Imaging Tech\u00adno\u00adlo\u00adgies GmbH has successfully closed a Series A finan\u00adcing round with a volume of more than USD 30 million. Both exis\u00adting and new inves\u00adtors, inclu\u00adding promi\u00adnent venture capi\u00adtal inves\u00adtors from the U.S., Israel, Luxem\u00adbourg, Portu\u00adgal and invest\u00adment compa\u00adnies from German Landes\u00adban\u00adken, parti\u00adci\u00adpa\u00adted in the finan\u00adcing round to support NVision Imaging&nbsp;[\u2026]<\/p>\n","protected":false},"author":2,"featured_media":49122,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1365,1366,1367,1368,1369],"tags":[],"class_list":["post-49124","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-private-equity-en","category-news-en","category-lawyers-tax-advisors-auditors-en","category-lawyers-tax-consultants-auditors","category-investors"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Cancer Treatment: Series-A for NVision Imaging Technologies for USD 30 million. - FYB Financial Yearbook<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cancer Treatment: Series-A for NVision Imaging Technologies for USD 30 million. - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Ulm, Germany \u2014 NVision Imaging Tech\u00adno\u00adlo\u00adgies GmbH has successfully closed a Series A finan\u00adcing round with a volume of more than USD 30 million. Both exis\u00adting and new inves\u00adtors, inclu\u00adding promi\u00adnent venture capi\u00adtal inves\u00adtors from the U.S., Israel, Luxem\u00adbourg, Portu\u00adgal and invest\u00adment compa\u00adnies from German Landes\u00adban\u00adken, parti\u00adci\u00adpa\u00adted in the finan\u00adcing round to support NVision Imaging [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-25T12:11:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/07\/inhester-michael-portrait.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"Cancer Treatment: Series\u2011A for NVision Imaging Technologies for USD 30 million.\",\"datePublished\":\"2023-07-25T12:11:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/\"},\"wordCount\":212,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/07\/inhester-michael-portrait.jpg\",\"articleSection\":[\"General\",\"Featured\",\"Private equity\",\"News\",\"Lawyers\/Tax-advisors\/Auditors\",\"Lawyers, tax consultants, auditors\",\"Investors\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/\",\"url\":\"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/\",\"name\":\"Cancer Treatment: Series-A for NVision Imaging Technologies for USD 30 million. - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/07\/inhester-michael-portrait.jpg\",\"datePublished\":\"2023-07-25T12:11:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/07\/inhester-michael-portrait.jpg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/07\/inhester-michael-portrait.jpg\",\"width\":1920,\"height\":1280},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cancer Treatment: Series\u2011A for NVision Imaging Technologies for USD 30 million.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cancer Treatment: Series-A for NVision Imaging Technologies for USD 30 million. - FYB Financial Yearbook","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/","og_locale":"en_US","og_type":"article","og_title":"Cancer Treatment: Series-A for NVision Imaging Technologies for USD 30 million. - FYB Financial Yearbook","og_description":"Ulm, Germany \u2014 NVision Imaging Tech\u00adno\u00adlo\u00adgies GmbH has successfully closed a Series A finan\u00adcing round with a volume of more than USD 30 million. Both exis\u00adting and new inves\u00adtors, inclu\u00adding promi\u00adnent venture capi\u00adtal inves\u00adtors from the U.S., Israel, Luxem\u00adbourg, Portu\u00adgal and invest\u00adment compa\u00adnies from German Landes\u00adban\u00adken, parti\u00adci\u00adpa\u00adted in the finan\u00adcing round to support NVision Imaging [&hellip;]","og_url":"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2023-07-25T12:11:48+00:00","og_image":[{"width":1920,"height":1280,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/07\/inhester-michael-portrait.jpg","type":"image\/jpeg"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"Cancer Treatment: Series\u2011A for NVision Imaging Technologies for USD 30 million.","datePublished":"2023-07-25T12:11:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/"},"wordCount":212,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/07\/inhester-michael-portrait.jpg","articleSection":["General","Featured","Private equity","News","Lawyers\/Tax-advisors\/Auditors","Lawyers, tax consultants, auditors","Investors"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/","url":"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/","name":"Cancer Treatment: Series-A for NVision Imaging Technologies for USD 30 million. - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/07\/inhester-michael-portrait.jpg","datePublished":"2023-07-25T12:11:48+00:00","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/07\/inhester-michael-portrait.jpg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/07\/inhester-michael-portrait.jpg","width":1920,"height":1280},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/cancer-treatment-series-a-for-nvision-imaging-technologies-for-usd-30-million\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"Cancer Treatment: Series\u2011A for NVision Imaging Technologies for USD 30 million."}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/49124","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=49124"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/49124\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/49122"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=49124"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=49124"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=49124"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}